Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

This public procurement record has 2 releases in its history.

Tender

16 Nov 2026 at 10:30

Planning

05 Nov 2026 at 12:23

Summary of the contracting process

Cambridge University Hospitals NHS Foundation Trust is buying a digital PCR (dPCR or digital droplet PCR) system for its Cambridge Genomics Lab. The equipment will support highly sensitive quantitative molecular testing for haematological cancers, including diagnosis, disease monitoring and assessment of treatment response. It is intended to complement existing next-generation sequencing, quantitative PCR and fragment analysis, and to bring several current assays and methods onto one platform. The requirement covers supply, delivery, installation and commissioning of the system, as well as post-warranty maintenance. This is laboratory and molecular diagnostics equipment (CPV 38950000). Delivery is in Cambridge, England.

The buyer invited offers through an open procedure. The procurement has reached the tender stage. The enquiry deadline was 14 December 2026 at 13:00, and the submission deadline was 16 December 2026 at 13:00; electronic submission was permitted. The contract period is scheduled to run from 1 March 2027 to 28 February 2034. The estimated value is £270,000 excluding VAT (£324,000 including VAT). There is one lot. Evaluation gives 40% to clinical and laboratory requirements, 25% to technical requirements, 10% to social value factors and 25% to whole-life costs. The award decision was scheduled for completion by 15 February 2027.

This requirement suits suppliers of digital PCR or digital droplet PCR systems with the ability to provide an end-to-end laboratory installation: equipment supply, delivery, commissioning and maintenance after the warranty period. A strong offer will need to demonstrate that the system meets clinical and laboratory needs and technical requirements, and can support sensitive quantitative testing of genomic alterations in haematological oncology. Suppliers with experience integrating molecular diagnostics platforms into genomics laboratories, consolidating multiple assays onto a single system, and supporting equipment over an extended service period are likely to be well placed. The evaluation also gives weight to social value and whole-life cost, so bidders should address both alongside clinical performance and technical suitability. The stated scope is a single system for a specialist hospital laboratory.

How relevant is this notice?

Notice Information

Notice Title

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Notice Description

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory's existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

Planning Information

The Authority conducted a preliminary market engagement with the following companies to understand the available market options with loan instruments to complete the proof of concept runs. Indicative pricings were also obtained in the engagement process. The engagement companies were: - Bio-Rad Laboratories, Inc. - Qiagen N.V. - Thermo Fisher Scientific Inc.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07b3e7
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/108335-2026
Current Stage
Tender
All Stages
Planning, Tender

Procurement Classification

Notice Type
UK4 - Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)


CPV Codes

38950000 - Polymerase Chain Reaction (PCR) equipment

Notice Value(s)

Tender Value
£270,000 £100K-£500K
Lots Value
£270,000 £100K-£500K
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Nov 2026Today
Submission Deadline
16 Dec 20265 weeks to go
Future Notice Date
20 Nov 20263 days to go
Award Date
Not specified
Contract Period
1 Mar 2027 - 28 Feb 2034 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CAMBRIDGE
Postcode
CB2 0QQ
Postcode Area
Cambridge
Country
England

Major Region (ITL 1)
TLH East (England)
Basic Region (ITL 2)
TLH4 Cambridgeshire and Peterborough
Small Region (ITL 3)
TLH42 Cambridgeshire CC
Delivery Location
TLH12 Cambridgeshire CC

Local Authority
Cambridge
Electoral Ward
Queen Edith's
Westminster Constituency
South Cambridgeshire

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...